Cited by 31Sexual function and dysfunction studiesUrinary Bladder and Prostate ResearchUrological Disorders and Treatments

Erectile function recovery in men treated with phosphodiesterase type 5 inhibitor administration after bilateral nerve‐sparing radical prostatectomy: a systematic review of placebo‐controlled randomized trials with trial sequential analysis

Limoncin, E., Gravina, G. L., Corona, G., Maggi, M., Ciocca, G., Lenzi, A., Jannini, E. A.·2017·Andrology

Abstract

The impact of phosphodiesterase type 5 inhibitor (PDE5I) treatment modality (on-demand vs. daily), PDE5I half-life and time from surgery to PDE5I prescription on the achievement of drug-assisted erectile function (EF) recovery is uncertain. We systematically reviewed published randomized clinical trials (RCTs). We performed meta-analyses of data on 2317 men treated with PDE5Is after nerve-sparing radical prostatectomy (NSRP). A PubMed and SCOPUS search was performed for trials published from 1 January 1969 to 30 June 2016. PDE5Is are effective in achieving drug-assisted recovery of erectile function (EF). From a statistical standpoint, these studies were subjected to Trial Sequential Analysis to determine whether the pooled data were adequately powered to verify the study outcomes. On-demand treatment with PDE5Is was significantly better than daily treatment in recovering drug-assisted EF. This effect was maintained even when the drugs were stratified according with half-life. Although not based on head-to-head trials, Avanafil used on-demand was the most effective PDE5I in recovering drug-assisted EF. Whereas tadalafil was equally effective when used both on-demand and daily, vardenafil significantly improved drug-assisted EF recovery only when used on-demand. The start of PDE5I treatment six months or more after surgery compared to treatment started earlier did not negatively affect the rate of drug-assisted EF recovery or the possibility to have successful intercourse based on the Sexual Encounter Profile question-3 (SEP-3). Current trials do not support the hypothesis that PDE5I use recovers drug-unassisted EF, although chronic low-dose tadalafil administration may help to preserve erectile tissue integrity. Potential shortcomings in the trials design may partially explain these disappointing results and several questions concerning the recovery of drug-unassisted EF remain unanswered. Thus, there is a need for well-designed new RCTs requiring changes in the timing of PDE5I administration as well as in the dose and the treatment duration.

Integrity signals

Registry

Crossref · 10.1111/andr.12403

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Limoncin, E., Gravina, G. L., Corona, G., Maggi, M., Ciocca, G., Lenzi, A., & Jannini, E. A.
Affiliations
  • University of Rome Tor Vergata (IT)
  • University of L'Aquila (IT)
  • Azienda USL di Bologna (IT)
  • University of Florence (IT)
  • Sapienza University of Rome (IT)
Corresponding author
Jannini, E. A.
Venue
Andrology
Publisher
Wiley
Published
2017-08-08
Volume
5
Issue
5
Pages
863-872
ISSN
  • 2047-2919 (ISSN-L)
  • 2047-2927
OpenAlex
W2744564831
Cited by
31
References
45
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 4
FWCI
0.54
Type
journal article
Language
en
Open access
closed
Locations
  • Andrology (publishedVersion)
  • PubMed (publishedVersion)
  • Florence Research (University of Florence) (submittedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Funders
Italian Ministry of University (2015XCR88M, RBAP109BLT_004)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
  • Health Sciences › Medicine › Urology › Urological Disorders and Treatments
Keywords
erectile function recovery, phosphodiesterase-5 inhibitors, nerve-sparing radical prostatectomy, prostate cancer, avanafil, tadalafil, vardenafil, trial sequential analysis
MeSH terms
Humans, Erectile Dysfunction, Male, Penile Erection, Prostatectomy, Randomized Controlled Trials as Topic, Phosphodiesterase 5 Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review